SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000905718-19-000938
Filing Date
2019-11-14
Accepted
2019-11-14 16:15:57
Documents
1
Group Members
ABINGWORTH BIOVENTURES VI, LP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A proteon13dam2nov122019.htm SC 13D/A 46847
  Complete submission text file 0000905718-19-000938.txt   48323
Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Subject) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88372 | Film No.: 191220388
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 (0)20 7534 1500
Abingworth LLP (Filed by) CIK: 0001397144 (see all company filings)

IRS No.: 980518585 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: SC 13D/A